from Argus Research issued a price target of $114.00 for CVS on 2026-08-19 12:45:11.The adjusted price target was set to $114.00.At the time of the announcement, CVS was trading at $95.58.The overall price target consensus is at $110.21 with high price of $126.00, low price of $92.00, and median price is at $110.50.CVS currently trades...
Bill Selesky from Argus Research issued a price target of $153.00 for COP on 2026-08-19 12:43:32.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for CVE on August 19, 2026 01:17PM ET. The previous...
Key Points - Marvell Technology sees a 13% increase in stock value after issuing a warrant...
Key Points - Nvidia's revenue growth and margins remain high due to supply-chain constraints elongating its...
from Argus Research issued a price target of $114.00 for CVS on 2026-08-19 12:45:11.The adjusted price target was set to $114.00.At the time of the announcement, CVS was trading at...
Bill Selesky from Argus Research issued a price target of $153.00 for COP on 2026-08-19 12:43:32.The adjusted price target was set to $153.00.At the time of the announcement, COP was...
from Truist Financial issued a price target of $62.00 for PYPL on 2026-08-19 11:49:07.The adjusted price target was set to $62.00.At the time of the announcement, PYPL was trading at...
from UBS issued a price target of $80.00 for D on 2026-08-19 06:55:00.The adjusted price target was set to $80.00.At the time of the announcement, D was trading at $68.64.The...
Michael Roxland from Truist Financial issued a price target of $51.00 for AMCR on 2026-08-18 13:06:00.The adjusted price target was set to $51.00.At the time of the announcement, AMCR was...
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...
In a landscape of fluctuating markets and regulatory uncertainties, the company experienced a remarkable revenue surge, reaching $36,077 million. Despite operational challenges, net income stood at $7,713 million. Management emphasized...
In the bustling corridors of Merck, management reflects on a transformative quarter. With net income rising to 5,085 million, the company celebrates strategic wins in oncology and diabetes, driven by...
In 2025, the company embraced growth through increased research and development, despite rising operating expenses. A net income of $24,780 million marked a decline, reflecting challenges in a fluctuating market....
In the first quarter of 2025, the company experienced a 9% revenue growth, fueled by increased sales and services. Operating expenses rose, reflecting evolving cost structures, while net income showed...
Truist Bank has recently announced a strategic partnership with Trovata, a leading provider of bank application programming interfaces (APIs) and enterprise cash management services. The partnership is expected to greatly...
Yesterday, two Exchange-Traded Funds (ETFs) captured the attention of investors due to their unusually high trading volumes. These two highly popular ETFs, the Nasdaq-100 ETF and the bonds ETF, have...
Truist Bank, one of the largest financial institutions in the United States, has announced a strategic partnership with Trovata, a leading provider of bank application programming interfaces (APIs) and enterprise...
Amazon, the retail giant that generates a staggering $540 billion in annual revenue, is scheduled to report its third-quarter earnings on October 26. Despite already gaining over 50% in stock...
Verizon's stock is experiencing a tremendous surge, poised to have its best day in 15 years. The telecom giant exceeded analyst expectations both in terms of revenue and profit margins....
